Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Valmori

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cancer Research|May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancerD Valmori, M J Pittet, D Rimoldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequencesP Romero, V Dutoit, V Rubio-Godoy, et al.
Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2001
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-lifeV Rubio-Godoy, V Dutoit, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995
Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparumU Blum-Tirouvanziam, C Servis, A Habluetzel, et al.
The Journal of Experimental Medicine|September 28, 1999
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytesD E Speiser, M J Pittet, D Valmori, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cancer Research|May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancerD Valmori, M J Pittet, D Rimoldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequencesP Romero, V Dutoit, V Rubio-Godoy, et al.
Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2001
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-lifeV Rubio-Godoy, V Dutoit, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995
Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparumU Blum-Tirouvanziam, C Servis, A Habluetzel, et al.
The Journal of Experimental Medicine|September 28, 1999
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytesD E Speiser, M J Pittet, D Valmori, et al.
Pageof 5